3 news items
MAIA Biotechnology (MAIA) is one of the earliest pioneers of telomere targeting as a therapeutic strategy
INCY
JAZZ
MIRA
23 Jul 24
by virtue of any person’s use of or access to this content.
Source
Mira Pharmaceuticals Announces DEA Rules MIRA-55, a Novel Oral Pharmaceutical Marijuana Analog, Is Not Classified as a Controlled Substance
MIRA
29 May 24
accessible research and development processes and reduces legal and logistical barriers to further studies and eventual commercialization
MIRA Pharmaceuticals in Discussions with Memorial Sloan Kettering to Collaborate on Preclinical Cancer Pain Model Utilizing The Company's Novel Oral Ketamine Analog
MIRA
21 May 24
accessible treatment options, including the ability to treat depression, which is common among cancer patients. This collaboration marks a significant step
- Prev
- 1
- Next